Anixa Biosciences (ANIX) Change in Accured Expenses (2010 - 2026)
Anixa Biosciences' Change in Accured Expenses was $212,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 14.6% from $185,000 a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Change in Accured Expenses (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anixa Biosciences' Change in Accured Expenses was $610,000 through Jul 31, 2026, up 735.6% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at -$185,000.
- In earlier fiscal years, Change in Accured Expenses was $176,000 in FY2024 (+300.0%), $44,000 in FY2023 (-93.0%), $631,000 in FY2022 (+226.9%) and $193,000 in FY2021.
- The fiscal Q3 2026 figure marks the highest quarterly Change in Accured Expenses since fiscal Q4 2024.
- Compared with a year earlier, Change in Accured Expenses was higher in three of the last five quarters, with growth averaging 54.1%.
- The best year-over-year quarter for Change in Accured Expenses over five years was fiscal Q4 2022 (growth of 407.7%); the worst was fiscal Q4 2025 (a decline of 96.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | 212,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 212,000.00 |
| Oct 31, 2025 | 10,000.00 |
| Jul 31, 2025 | 185,000.00 |
| Apr 30, 2025 | 203,000.00 |
| Jan 31, 2025 | -583,000.00 |
| Oct 31, 2024 | 268,000.00 |
| Jul 31, 2024 | 268,000.00 |
| Apr 30, 2024 | 168,000.00 |
| Jan 31, 2024 | -528,000.00 |
| Oct 31, 2023 | 58,000.00 |
| Jul 31, 2023 | 419,000.00 |
| Apr 30, 2023 | 218,000.00 |
| Jan 31, 2023 | -651,000.00 |
| Oct 31, 2022 | 528,000.00 |
| Jul 31, 2022 | 140,000.00 |
| Apr 30, 2022 | -184,000.00 |
| Jan 31, 2022 | 147,000.00 |
| Oct 31, 2021 | 104,000.00 |
| Jul 31, 2021 | 12,000.00 |
| Apr 30, 2021 | 5,000.00 |
API Access
Anixa Biosciences Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();